학술논문
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
Document Type
Academic Journal
Author
Source
Annals of Oncology. Nov 01, 2017 28(11):2754-2760
Subject
Language
English
ISSN
0923-7534